New Antipsychotic Combenfy: Marketing or Medical Advance?
March 11, 2026
8,949
653
61
7.98%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr Josef Episodes Around March 11, 2026
See what was published immediately before and after this episode.
2:24Now PlayingNew Antipsychotic Combenfy: Marketing or Medical Advance?
YouTube Description
as posted by the channelThe hype around a new antipsychotic, Combenfy, isn't about progress, but profit. Elite psychiatrists, paid consultants for drug companies including the developer, are promoting it. This drug, costing $2000/month, has significant GI and urinary side effects, though fewer movement disorders. #Antipsychotics #Combenfy #PharmaMarketing #Psychiatry #Healthcare
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.